Regulation of interleukin-4 signaling by extracellular reduction of intramolecular disulfides.
暂无分享,去创建一个
A. Karlsson | R. Gaudin | N. Ahlborg | M. Johansson | M. Lundberg | M. Troye-Blomberg | S. Curbo | M. Carlsten | Karl-Johan Malmberg
[1] J. Wood,et al. Thioredoxin reductase activity at the surface of human primary cutaneous melanomas and their surrounding skin , 2007, International journal of cancer.
[2] S. Holgate,et al. IL-4 Receptor α Is an Important Modulator of IL-4 and IL-13 Receptor Binding: Implications for the Development of Therapeutic Targets1 , 2006, The Journal of Immunology.
[3] J. Gibbins,et al. Extracellular disulfide exchange and the regulation of cellular function. , 2006, Antioxidants & redox signaling.
[4] I. Jones,et al. Protein-disulfide Isomerase-mediated Reduction of Two Disulfide Bonds of HIV Envelope Glycoprotein 120 Occurs Post-CXCR4 Binding and Is Required for Fusion* , 2003, The Journal of Biological Chemistry.
[5] C. Broder,et al. Inhibitors of Protein-Disulfide Isomerase Prevent Cleavage of Disulfide Bonds in Receptor-bound Glycoprotein 120 and Prevent HIV-1 Entry* , 2002, The Journal of Biological Chemistry.
[6] Kenneth M. Murphy,et al. Decision making in the immune system: The lineage decisions of helper T cells , 2002, Nature Reviews Immunology.
[7] C. Turano,et al. Proteins of the PDI family: Unpredicted non‐ER locations and functions , 2002, Journal of cellular physiology.
[8] P. Li,et al. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1 , 2002, Nature Immunology.
[9] A. Shigematsu,et al. Thioredoxin is associated with endotoxin tolerance in mice , 2002, Critical care medicine.
[10] W. Busse,et al. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. , 2001, The Journal of allergy and clinical immunology.
[11] Elias S. J. Arnér,et al. Physiological functions of thioredoxin and thioredoxin reductase. , 2000, European journal of biochemistry.
[12] M. Kashimura,et al. Expression of thioredoxin and thioredoxin reductase in placentae of pregnant mice exposed to lipopolysaccharide. , 1999, Placenta.
[13] K. Dabbagh,et al. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. , 1999, Journal of immunology.
[14] G. Aversa,et al. Receptors and cytokines involved in allergic TH2 cell responses. , 1999, The Journal of allergy and clinical immunology.
[15] P. Reinemer,et al. Crystal Structure of the Interleukin-4/Receptor α Chain Complex Reveals a Mosaic Binding Interface , 1999, Cell.
[16] P. Hogg,et al. Redox Control of Exofacial Protein Thiols/Disulfides by Protein Disulfide Isomerase* , 1999, The Journal of Biological Chemistry.
[17] K. Vasquez,et al. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] K. Kajiwara,et al. A thiol antioxidant regulates IgE isotype switching by inhibiting activation of nuclear factor-kappaB. , 1997, The Journal of allergy and clinical immunology.
[19] R. Pawankar,et al. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. , 1997, The Journal of clinical investigation.
[20] Kenneth M. Murphy,et al. Functional diversity of helper T lymphocytes , 1996, Nature.
[21] J. Bonnefoy,et al. Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis , 1995, The Journal of experimental medicine.
[22] M. Schilsky,et al. Secretion, Surface Localization, Turnover, and Steady State Expression of Protein Disulfide Isomerase in Rat Hepatocytes (*) , 1995, The Journal of Biological Chemistry.
[23] E. Levy,et al. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[24] D. S. Garrett,et al. Three-dimensional solution structure of human interleukin-4 by multidimensional heteronuclear magnetic resonance spectroscopy. , 1993, Science.
[25] R. Sitia,et al. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. , 1992, The Journal of biological chemistry.
[26] W. Sebald,et al. Site‐directed mutagenesis reveals the importance of disulfide bridges and aromatic residues for structure and proliferative activity of human Interleukin‐4 , 1991, FEBS letters.
[27] M. Dean,et al. Identification of a thioredoxin-related protein associated with plasma membranes. , 1991, Biochemical and biophysical research communications.
[28] A. Levine,et al. Disulfide assignments in recombinant mouse and human interleukin 4. , 1991, Biochemistry.
[29] T. Yoshimori,et al. Protein disulfide-isomerase in rat exocrine pancreatic cells is exported from the endoplasmic reticulum despite possessing the retention signal. , 1990, The Journal of biological chemistry.
[30] K. Arai,et al. ATL‐derived factor (ADF), an IL‐2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol‐reduction in the IL‐2 receptor induction. , 1989, The EMBO journal.
[31] H. Hansson,et al. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. , 1985, European journal of cell biology.
[32] W. Buchanan,et al. Disease-modifying drugs series editor : T. PULLAR AURANOFIN , 1997 .
[33] A. Vazquez,et al. N-acetylcysteine (NAC) enhances interleukin-2 but suppresses interleukin-4 secretion from normal and HIV+ CD4+ T-cells. , 1995, Cellular and molecular biology.
[34] R. Coffman,et al. Mechanism and regulation of immunoglobulin isotype switching. , 1993, Advances in immunology.